Herpes simplex virus vaccines as immunotherapeutic agents

This publication has 19 references indexed in Scilit:

• BIOLOGICAL THERAPY IN VIRUS DISEASES.*
  British Journal of Dermatology, 2006
• Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes
  The Lancet, 1994
• Immunotherapy of persistent viral infections
  Reviews in Medical Virology, 1994
• Immunotherapy of Acute and Recurrent Herpes Simplex Virus Type 2 Infection with an Adjuvant-Free Form of Recombinant Glycoprotein D-Interleukin-2 Fusion Protein
  The Journal of Infectious Diseases, 1994
• Herpes simplex virus glycoprotein immunotherapy of recurrent genital herpes: Factors influencing efficacy
  Antiviral Research, 1989
• Herpes simplex virus glycoprotein treatment of recurrent genital herpes reduces cervicovaginal virus shedding in guinea pigs
  Antiviral Research, 1988
• Placebo-controlled study with subunit herpes simplex virus vaccine in subjects suffering from frequent herpetic recurrences
  Vaccine, 1988
• Herpes Simplex Virus Glycoprotein Treatment of Recurrent Genital Herpes
  The Journal of Infectious Diseases, 1988
• STUDIES ON HERPES SIMPLEX VIRUS VI. OBSERVATIONS ON PATIENTS WITH RECURRENT HERPETIC LESIONS INJECTED WITH HERPES VIRUSES OR THEIR ANTIGENS
  The Lancet Healthy Longevity, 1955
• Formolized Herpes Virus Therapy and the Neutralizing Substance in Herpes Simplex11From the Dermatology Department, Vanderbilt Clinic (Professor J. Gardner Hopkins); the Bacteriology Department) College of Physicians and Surgeons, (Professor Frederick P. Gay), and the New York Post-Graduate Medical School and Hospital, Skin and Cancer Unit, (George M. MacKee, Director), of Columbia University.
  Journal of Investigative Dermatology, 1938